Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.033 AUD | 0.00% |
|
-13.51% | -67.01% |
Jun. 19 | Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15% | MT |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Stephen Becker
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-16 |
Corporate Secretary | 67 | 99-02-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Thomas
BRD | Director/Board Member | 79 | 12-03-06 |
Michael Hoy
CHM | Chairman | 75 | 00-02-06 |
Michelle Miller
CEO | Chief Executive Officer | - | 02-06-20 |
Susan Pond
BRD | Director/Board Member | - | 12-03-06 |
Director/Board Member | - | 18-10-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 901,944,902 | 724,063,389 ( 80.28 %) | 0 | 80.28 % |
Company contact information
![address Biotron Limited(BIT)](https://cdn.zonebourse.com/static/address/10353335.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-67.01% | 23.74M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- BIT Stock
- Company Biotron Limited